Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Nina Rosa, Neuendorff"'
Autor:
Tamas Fulop, Abdullah M Khan, Valentín Ortiz-Maldonado, Marcus Vetter, Rainer Wirth, Fabian Ullrich, Paul J Bröckelmann, Amin T Turki, Elena-Diana Chiru, Bastian von Tresckow, Raul Cordoba, Nina Rosa Neuendorff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 12 (2024)
The treatment landscape for lymphoma and multiple myeloma, which disproportionally affect older adults, has been transformed by the advent of T cell-mediated immunotherapies, including immune checkpoint inhibition, T cell-engaging bispecific antibodi
Externí odkaz:
https://doaj.org/article/8afaf79800064ff3a516fd0cd7446516
Autor:
Johannes Maurus, Tobias Terzer, Axel Benner, Sabine Goisser, Annette Eidam, Anja Roth, Maike Janssen, Sonia Jaramillo, Hannes Martin Lorenz, William Micol, Klaus Hauer, Carsten Müller‐Tidow, Jürgen M. Bauer, Karin Jordan, Nina Rosa Neuendorff
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 1, Pp 264-275 (2022)
Abstract Background The strength, assistance walking, rise from a chair, climb stairs, and falls (SARC‐F) questionnaire is a well‐established instrument for screening of sarcopenia and sarcopenia‐related functional impairments. As it is based o
Externí odkaz:
https://doaj.org/article/13d886f9e83244529c3f10f613406c69
Autor:
Nina Rosa Neuendorff, Boryana Boshikova, Lutz Frankenstein, Marietta Kirchner, Christian Rohde, Hartmut Goldschmidt, Norbert Frey, Carsten Müller-Tidow, Karin Jordan, Sandra Sauer, Maike Janssen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIn patients with cardiovascular (CV) comorbidities that necessitate antiplatelet therapy (APT), its optimal management during chemotherapy-induced thrombocytopenia remains elusive, as the risk of bleeding has to be balanced against the risk
Externí odkaz:
https://doaj.org/article/dd86f3942f5c4fe18bcd605ba73e2f12
Autor:
Jana Ihlow, Sophia Gross, Leonie Busack, Anne Flörcken, Julia Jesse, Michaela Schwarz, Nina Rosa Neuendorff, Ann-Christin von Brünneck, Ioannis Anagnostopoulos, Seval Türkmen, Igor Wolfgang Blau, Thomas Burmeister, David Horst, Lars Bullinger, Jörg Westermann
Publikováno v:
Haematologica, Vol 107, Iss 8 (2021)
In acute myeloid leukemia, there is an ongoing debate on the prognostic value of the early bone marrow assessment in patients receiving intensive therapy. In this retrospective study, we analyzed the prognostic impact of the early response in 1,008 p
Externí odkaz:
https://doaj.org/article/26889bf2ca9348febca36380618bd78d
Autor:
Nina Rosa Neuendorff, Philipp Hemmati, Renate Arnold, Jana Ihlow, Bernd Dörken, Carsten Müller-Tidow, Jörg Westermann
Publikováno v:
Blood Advances, Vol 2, Iss 12, Pp 1409-1411 (2018)
Externí odkaz:
https://doaj.org/article/85c1f734795444d9aeac287b52160ea8
Autor:
Robert Devich, Nina Rosa Neuendorff, Oscar Howard Frazier, Howard J. Eisen, Robert Dowling, Miriam Freundt
Publikováno v:
ASAIO Journal.
Autor:
Nina Rosa Neuendorff, Leonie Busack, Thomas Burmeister, Jana Ihlow, David Horst, Julia Jesse, Lars Bullinger, Sophia Gross, Seval Türkmen, Ioannis Anagnostopoulos, Ann-Christin von Brünneck, Anne Flörcken, Jörg Westermann, Michaela Schwarz, Igor Wolfgang Blau
In acute myeloid leukemia, there is an ongoing debate on the prognostic value of the early bone marrow assessment in patients receiving intensive therapy. In this retrospective study, we analyzed the prognostic impact of the early response in 1,008 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3212dba40bc2d955a4a7fa924a243124
http://edoc.mdc-berlin.de/21131/2/21131suppl.pdf
http://edoc.mdc-berlin.de/21131/2/21131suppl.pdf
Autor:
Hira S. Mian, Tanya M. Wildes, Melina Boutin, Smith Giri, Ashley E. Rosko, Shakira J. Grant, Nikita Nikita, Nina Rosa Neuendorff, Sonja Zweegman, Jessica L. Krok-Schoen, Lorenzo Dottorini
Publikováno v:
Grant, S J, Mian, H S, Giri, S, Boutin, M, Dottorini, L, Neuendorff, N R, Krok-Schoen, J L, Nikita, N, Rosko, A E, Wildes, T M & Zweegman, S 2021, ' Transplant-ineligible newly diagnosed multiple myeloma : Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper ', Journal of Geriatric Oncology, vol. 12, no. 4, pp. 499-507 . https://doi.org/10.1016/j.jgo.2020.12.001
J Geriatr Oncol
J Geriatr Oncol
Multiple myeloma is the second most common hematological malignancy in the USA and Europe. Despite improvements in the 5-year and overall survival rates over the past decade, older adults (aged ≥65 years) with multiple myeloma continue to experienc
Autor:
Michaela Schwarz, Igor Wolfgang Blau, Lars Bullinger, Nina Rosa Neuendorff, Leonie Busack, Seval Türkmen, Ioannis Anagnostopoulos, Anne Flörcken, Anju Singh, Alma Herneth, Thomas Burmeister, Jana Ihlow, Sophia Gross, Jörg Westermann
Publikováno v:
Journal of Geriatric Oncology. 12:540-549
Objective In older adults with acute myeloid leukemia (AML), the overall outcome is still dismal and long-term data on survival are scarce, particularly outside of clinical trials. Here, we assess characteristics, prognostic factors and long-term sur
Autor:
Nina Rosa Neuendorff
Publikováno v:
Kompass Onkologie. 9:122-124
We conducted a randomized controlled trial in older adults with hematologic malignancies to determine the impact of geriatrician consultation embedded in our oncology clinic alongside standard care. From February 2015 to May 2018, transplant-ineligib